Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Durham

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, Dean Pavlick, Akihide Yoshimi, et al.
Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulationGaurav Agarwal, Mateusz Antoszewski, Xueqin Xie, et al.
Science (New York, N.Y.)|January 1, 2026
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulationGaurav Agarwal, Mateusz Antoszewski, Xueqin Xie, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.
The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Blood Advances|May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular featuresRivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, Dean Pavlick, Akihide Yoshimi, et al.
Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulationGaurav Agarwal, Mateusz Antoszewski, Xueqin Xie, et al.
Science (New York, N.Y.)|January 1, 2026
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulationGaurav Agarwal, Mateusz Antoszewski, Xueqin Xie, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.
The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Blood Advances|May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular featuresRivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.
Pageof 7